Session Details Page | International Bar Association

Personalised medicine and gene therapy: understanding legal and commercial challenges in transnational contexts

27 Mar 2026

Session information

Personalised medicine and gene therapy: understanding legal and commercial challenges in transnational contexts

Friday 27 March (1301 - 1429)

Committee(s)

Healthcare and Life Sciences Law Committee (Lead)
Intellectual Property and Entertainment Law Committee

Session / Workshop Chair(s)

Benjamin Gaw	Drew & Napier, Singapore, Singapore

Speakers

Renata Fialho de Oliveira	Veirano Advogados, São Paulo, Brazil; Co-Chair, Healthcare and Life Sciences Law Committee
Margaux Hall	Ropes & Gray , Washington, District of Columbia, USA
Hilary Jones	Formerly at BioNTech UK Ltd , London, England
Emmanuel Savoiz	TigenPharma, Lausanne, Switzerland
Elisa Stefanini	Portolano Cavallo, Rome, Italy; Chair, Digital Healthcare and Regulation Subcommittee
Koen T'Syen	Van Bael & Bellis, Brussels, Belgium
Simona Valente	AGC Biologics, Milan, Italy
Ilaria Villa	Fondazione Telethon, Rome, Italy

International Bar Association is incorporated as a Not-for-Profit Corporation under the laws of the State of New York in the United States of America and is registered with the Department of State of the State of New York with registration number 071114000655 - and the liability of its members is limited. Its registered address in New York is c/o Capitol Services Inc, 1218 Central Avenue, Suite 100, Albany, New York 12205.

The London office of International Bar Association is registered in England and Wales as a branch with registration number FC028342.